Adherium (ADR.AX) traded up 6.35 % during a 24 hours period ending at 03:39 AM Central Europe on Wednesday 28th. One Adherium stock can currently be bought for about AUD 0.07 on popular exchanges. Current supply of Adherium stocks is 54.9 mn. Adherium has a current market capitalization of AUD 3.7 mn and approximately AUD 4.8 k worth of Adherium was traded on exchanges in the last 24 hours. Since last month end, Adherium has traded -18.29 % down. Simple moving average of last 200 days is at AUD 0.2. The highest price of past 52 weeks was recorded at AUD 0.67 on 01/09/2026. 52 weeks low was at AUD 0.06 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Chatham Rock Phosphate (3GRE.F) traded flat 0 % and now trades at CAD 0.03. Current market capitalisation for Chatham Rock Phosphate is CAD 2.1 mn.
Mustang Bio (MBIO) traded down -2.7 % and now trades at USD 0.36. Mustang Bio has a market capitalisation of USD 2.8 mn.
Clearmind Medicine (CMND) traded up 4.28 % and now trades at USD 5.96. Current market capitalisation for Clearmind Medicine is USD 3 mn.
Aptevo Therapeutics (APVO) traded down -6.83 % and now trades at USD 1.28. Aptevo Therapeutics has a market capitalisation of USD 3.1 mn.
Lkl Bhd (0182.KL) traded flat 0 % and now trades at MYR 0.03. Lkl Bhd has a market capitalisation of MYR 11.6 mn.
About Adherium
Adherium Limited is a digital health company operating in New Zealand with its base in Auckland. The company specializes in providing technologies for medication use and remote patient management in chronic diseases. Additionally, Adherium develops and manufactures solutions to monitor and increase patient adherence to therapies. Their web address is www.adherium.com , and they are listed on the ASX All Markets stock exchange.